46.46.Z - Wholesale trade of pharmaceutical and medical products
62.03.Z - Activities related to programming, IT consulting, and related activities
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
69.20.Z - Accounting, bookkeeping and tax consultancy
70.21.Z - Head office activities and management consultancy
73.1 - Advertising
73.20.Z - Market research and public opinion polling
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
82.99.Z - Other business support activities, not elsewhere classified
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 110,1 | 92,3 | 70,8 | -23,3 |
EBITDA | 124,6 | 68,2 | 41,4 | -39,3 |
Short time liabilities | 258,2 | 295,5 | 189,3 | -35,9 |
Equity capital | 772,4 | 621,9 | 679,2 | 9,2 |
Operating profit (EBIT) | 109,6 | 64,7 | 40,1 | -38 |
Assets | 1078,9 | 945,1 | 899 | -4,9 |
Net profit (loss) | 87,3 | 74,7 | 57,4 | -23,2 |
Cash | 12,1 | 9 | 1 | -88,8 |
Net income from sale | 1619 | 1206,8 | 1158,8 | -4 |
Liabilities and provisions for liabilities | 306,4 | 323,2 | 219,8 | -32 |
Working assets | 932,8 | 927 | 699 | -24,6 |
Depreciation | 15 | 3,5 | 1,3 | -62,2 |
% | % | % | p.p. | |
Profitability of capital | 11,3 | 12 | 8,4 | -3,6 |
Equity capital to total assets | 71,6 | 65,8 | 75,5 | 9,7 |
Gross profit margin | 6,8 | 7,6 | 6,1 | -1,5 |
EBITDA Margin | 7,7 | 5,7 | 3,6 | -2,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 58 | 89 | 60 | -29 |
Current financial liquidity indicator | 3.4646172523498535 | 3.1013247966766357 | 3.6525607109069824 | 0,6 |
Net dept to EBITDA | -0.0972306877374649 | -0.13184773921966553 | 0.03747214749455452 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane